The ClinGen Evidence Repository is an FDA-recognized human genetic variant database containing expert-curated assertions regarding variants' pathogenicity and supporting evidence summaries. [Disclaimer]


Variant: NM_000162.5(GCK):c.1280_1283dup (p.Arg429fs)

CA1139660055

995103 (ClinVar)

Gene: GCK
Condition: maturity-onset diabetes of the young type 2
Inheritance Mode: Semidominant inheritance
UUID: 06ec1ad0-a52d-4f2c-8dab-878211c0d73b

HGVS expressions

NM_000162.5:c.1280_1283dup
NM_000162.5(GCK):c.1280_1283dup (p.Arg429fs)
NC_000007.14:g.44145254_44145257dup
CM000669.2:g.44145254_44145257dup
NC_000007.13:g.44184853_44184856dup
CM000669.1:g.44184853_44184856dup
NC_000007.12:g.44151378_44151381dup
NG_008847.1:g.49170_49173dup
NG_008847.2:g.57917_57920dup
ENST00000395796.8:c.*1278_*1281dup
ENST00000616242.5:c.*400_*403dup
ENST00000683378.1:n.506_509dup
ENST00000336642.9:c.314_317dup
ENST00000345378.7:c.1283_1286dup
ENST00000403799.8:c.1280_1283dup
ENST00000671824.1:c.1343_1346dup
ENST00000672743.1:n.292_295dup
ENST00000673284.1:c.1280_1283dup
ENST00000336642.8:c.332_335dup
ENST00000345378.6:c.1283_1286dup
ENST00000395796.7:c.1277_1280dup
ENST00000403799.7:c.1280_1283dup
ENST00000437084.1:c.1229_1232dup
ENST00000459642.1:n.660_663dup
ENST00000616242.4:c.1277_1280dup
NM_000162.3:c.1280_1283dup
NM_033507.1:c.1283_1286dup
NM_033508.1:c.1277_1280dup
NM_000162.4:c.1280_1283dup
NM_001354800.1:c.1280_1283dup
NM_001354801.1:c.269_272dup
NM_001354802.1:c.140_143dup
NM_001354803.1:c.314_317dup
NM_033507.2:c.1283_1286dup
NM_033508.2:c.1277_1280dup
NM_033507.3:c.1283_1286dup
NM_033508.3:c.1277_1280dup
NM_001354803.2:c.314_317dup

Likely Pathogenic

Met criteria codes 2
PM2_Supporting PVS1
Not Met criteria codes 2
PS4 PP4

Evidence Links 0

Expert Panel

Criteria Specification Information

Criteria Specification: ClinGen Monogenic Diabetes Expert Panel Specifications to the ACMG/AMP Variant Interpretation Guidelines for GCK Version 1.2.0

Criteria Specification Approval History
Criteria Specifications for this VCEP
Evidence submitted by expert panel
Monogenic Diabetes VCEP
The c.1280_1283dup variant in the glucokinase gene, GCK, causes a frameshift in the protein at codon 429 (NM_000162.5), adding 31 novel amino acids before encountering a stop codon (p.(Arg429AlafsTer31)). While this variant, located in exon 10 of 10, is predicted to cause a premature stop codon and to escape nonsense mediated decay, it is in a functionally important region of a gene where loss-of-function is an established disease mechanism (PVS1). This variant is absent in gnomAD v2.1.1 (PM2_Supporting). This variant was identified in an individual with diabetes; however, PP4 is unable to be evaluated due to insufficient clinical information (internal lab contributors). In summary, c.1280_1283dup meets the criteria to be classified as likely pathogenic for monogenic diabetes. ACMG/AMP criteria applied, as specified by the ClinGen MDEP (specification version 1.3.0, approved 8/11/2023): PVS1, PM2_supporting.
Met criteria codes
PM2_Supporting
This variant is absent in gnomAD v2.1.1 (PM2_Supporting).
PVS1
Frameshift in exon 10While this variant, located in exon 10 of 10, is predicted to cause a premature stop codon and to escape nonsense mediated decay, it is in a functionally important region of a gene where loss-of-function is an established disease mechanism (PVS1).
Not Met criteria codes
PS4
One case at a clinical testing laboratory
PP4
This variant was identified in an individual with diabetes; however, PP4 is unable to be evaluated due to insufficient clinical information (internal lab contributors).
Approved on: 2023-11-03
Published on: 2023-11-03
The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. If you have questions about the information contained on this website, please see a health care professional.
¤ Powered by BCM's Genboree.